EA
Emerald Advisers’s Karyopharm Therapeutics KPTI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-46,470
| Closed | -$489K | – | 296 |
|
|
2021
Q1 | $489K | Sell |
46,470
-1,776,311
| -97% | -$18.7M | 0.02% | 198 |
|
|
2020
Q4 | $28.2M | Buy |
1,822,781
+219,528
| +14% | +$3.4M | 0.94% | 37 |
|
|
2020
Q3 | $23.4M | Buy |
1,603,253
+359,042
| +29% | +$5.24M | 0.96% | 38 |
|
|
2020
Q2 | $23.6M | Buy |
1,244,211
+198,663
| +19% | +$3.76M | 1.03% | 35 |
|
|
2020
Q1 | $20.1M | Buy |
1,045,548
+544,295
| +109% | +$10.5M | 1.16% | 25 |
|
|
2019
Q4 | $9.61M | Sell |
501,253
-995,330
| -67% | -$19.1M | 0.41% | 94 |
|
|
2019
Q3 | $14.4M | Buy |
1,496,583
+20,349
| +1% | +$196K | 0.67% | 56 |
|
|
2019
Q2 | $8.84M | Sell |
1,476,234
-31,860
| -2% | -$191K | 0.36% | 100 |
|
|
2019
Q1 | $8.81M | Buy |
1,508,094
+51,621
| +4% | +$301K | 0.36% | 103 |
|
|
2018
Q4 | $13.6M | Buy |
1,456,473
+762,405
| +110% | +$7.14M | 0.67% | 58 |
|
|
2018
Q3 | $11.8M | Buy |
694,068
+132,751
| +24% | +$2.26M | 0.43% | 97 |
|
|
2018
Q2 | $9.54M | Buy |
+561,317
| New | +$9.54M | 0.36% | 107 |
|